aTyr Pharma (LIFE)
(Delayed Data from NSDQ)
$1.73 USD
-0.03 (-1.70%)
Updated May 31, 2024 04:00 PM ET
After-Market: $1.74 +0.01 (0.58%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Brokerage Reports
0 items in cart
[LIFE]
Reports for Purchase
Showing records 141 - 160 ( 174 total )
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
4Q11 Results Review: Overcoming a Challenging Environment;First Look at 2012 Guidance is Encouraging
Provider: AURIGA USA
Analyst: MCDONALD P
Industry: Medical - Products
Industry: Medical - Products
3Q11 Results Review: China Rebounds; While CSI: Moscow Lends a Helping Hand
Provider: AURIGA USA
Analyst: MCDONALD P
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
2Q11 Results Review: Tough Academic Environment Compounded By China Reorg
Provider: AURIGA USA
Analyst: MCDONALD P
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
1Q11 Results Review-We are assuming coverage with a Buy rating and $63 price target
Provider: AURIGA USA
Analyst: MCDONALD P